EMA accepts GSK submission to add single-dose Bexsero booster for ages 10+
GSK•EMA accepts GSK filing for Bexsero label update
The European Medicines Agency accepted GSK’s filing to update Bexsero’s label to add a single booster dose for people aged 10+ previously vaccinated.
The submission is backed by a Phase 3b study showing one booster dose boosted immune responses in 10-20 year olds vaccinated in infancy.
